//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Theory"
~subject:"Pharmaceutical industry"
~isPartOf:"Health economics"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Pharmazeutisches Produkt"
Narrow search
Delete all filters
| 3 applied filters
Year of publication
From:
To:
Subject
All
Theory
Pharmaceutical industry
Arzneimittel
105
Pharmaceuticals
105
Gesundheitskosten
32
Health care costs
32
Pharmaindustrie
26
Gesetzliche Krankenversicherung
18
Public health insurance
18
Drogenkonsum
12
Drug consumption
12
Impfung
12
Vaccination
12
Elderly people
11
Health insurance
11
Krankenversicherung
11
Physicians
11
Theorie
11
Ältere Menschen
11
Ärzte
11
Coronavirus
9
Infectious disease
9
Infektionskrankheit
9
Estimation
8
Gesundheitspolitik
8
Health policy
8
Preis
8
Price
8
Schätzung
8
pharmaceuticals
8
Arzneimittelmarkt
7
Gesundheitsversorgung
7
Health care
7
Pharmaceutical market
7
Preisregulierung
7
Price regulation
7
Regulation
7
Regulierung
7
prescription drugs
7
Medicare Part D
6
more ...
less ...
Online availability
All
Undetermined
11
Free
4
Type of publication
All
Article
34
Type of publication (narrower categories)
All
Article in journal
34
Aufsatz in Zeitschrift
34
Language
All
English
34
Author
All
Danzon, Patricia Munch
2
Trivedi, Pravin K.
2
Zhang, Yuting
2
Adams, Christopher P.
1
Aggarwal, Mayank
1
Attema, Arthur Ewoud
1
Augurzky, Boris
1
Ayyagari, Padmaja
1
Birg, Laura
1
Bradford, David W.
1
Brantner, Van Vu
1
Breeze, Penny
1
Brennan, Alan
1
Cabrales, Antonio
1
Casado Marin, David
1
Chakrabarti, Anindya S.
1
Chatterjee, Chirantan
1
Claxton, Karl
1
Cook, Joseph P.
1
Datta, Anusua
1
Dave, Dhaval
1
Deb, Partha
1
Douven, Rudy
1
Feenstra, Talitha Lisbeth
1
García Gómez, Pilar
1
García-Mariñoso, Begoña
1
Golec, Joseph
1
Greß, Stefan
1
Göhlmann, Silja
1
He, Daifeng
1
Herrmann, Markus
1
Hollis, Aidan
1
Jelovac, Izabela
1
Jiménez-Martín, Sergi
1
Johansson, Naimi
1
Kaplan, Cameron
1
Kaplan, Cameron M.
1
Kleit, Andrew N.
1
Kong, Ying
1
Laat, Eric A. A. de
1
more ...
less ...
Published in...
All
Health economics
NBER working paper series
77
NBER Working Paper
57
Journal of health economics
44
Working paper / National Bureau of Economic Research, Inc.
43
International journal of pharmaceutical and healthcare marketing : IJPHM
37
The European journal of health economics : HEPAC ; health economics in prevention and care
35
Journal of medical marketing : device, diagnostic and pharmaceutical marketing
33
International journal of the economics of business
19
Research policy : policy, management and economic studies of science, technology and innovation
18
Health marketing quarterly
17
CESifo working papers
14
Management science : journal of the Institute for Operations Research and the Management Sciences
14
Applied economics
12
Health economics review
12
International journal of industrial organization
12
Research paper
12
Discussion papers / CEPR
11
Review of industrial organization : RIO
11
Technological forecasting & social change : an international journal
11
International journal of health economics and management
10
International journal of pharmaceutical and healthcare marketing
10
The European journal of health economics
10
Working papers / TSE : WP
10
OECD Health Statistics
9
Working paper
9
Cege discussion paper
8
Economics letters
8
Faculty & research / Insead : working paper series
8
Journal of business ethics : JOBE
8
European journal of operational research : EJOR
7
International journal of production economics
7
Journal of pharmaceutical finance, economics & policy
7
Manufacturing & service operations management : M & SOM
7
Applied economics letters
6
CESifo Working Paper Series
6
Health care management science
6
Indian pharmaceutical industry : strategies and challenges in formulations marketing
6
International journal of intellectual property management : IJIPM
6
Journal of global marketing
6
more ...
less ...
Source
All
ECONIS (ZBW)
34
Showing
1
-
34
of
34
Sort
Relevance
Date (newest first)
Date (oldest first)
1
Parallel imports under a manufacturer rebate and a price freeze : evidence from Germany
Birg, Laura
- In:
Health economics
32
(
2023
)
2
,
pp. 302-323
Persistent link: https://www.econbiz.de/10014266802
Saved in:
2
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
Liu, Judith
;
Zhang, Yuting
;
Kaplan, Cameron M.
- In:
Health economics
32
(
2023
)
3
,
pp. 639-653
Persistent link: https://www.econbiz.de/10014266837
Saved in:
3
Movies, stigma and choice : evidence from the pharmaceutical industry
Aggarwal, Mayank
;
Chakrabarti, Anindya S.
;
Chatterjee, …
- In:
Health economics
32
(
2023
)
5
,
pp. 1019-1039
Persistent link: https://www.econbiz.de/10014278027
Saved in:
4
Regional variation in prescription drug spending : evidence from regional migrants in Sweden
Johansson, Naimi
;
Svensson, Mikael
- In:
Health economics
31
(
2022
)
9
,
pp. 1862-1877
Persistent link: https://www.econbiz.de/10013433584
Saved in:
5
Achieving dynamic efficiency in pharmaceutical innovation : identifying the optimal share of value and payments required
Woods, Beth
;
Lomas, James
;
Sculpher, Mark
;
Weatherly, Helen
- In:
Health economics
33
(
2024
)
4
,
pp. 804-819
Persistent link: https://www.econbiz.de/10014514558
Saved in:
6
A structural analysis of physician agency and pharmaceutical demand
Tang, Meng-Chi
- In:
Health economics
32
(
2023
)
7
,
pp. 1453-1477
Persistent link: https://www.econbiz.de/10014329142
Saved in:
7
Incentives to implement personalized medicine under second-best pricing
Mougeot, Michel
;
Naegelen, Florence
- In:
Health economics
31
(
2022
)
11
,
pp. 2411-2424
Persistent link: https://www.econbiz.de/10013461826
Saved in:
8
The role of medical expenditure risk in portfolio allocation decisions
Ayyagari, Padmaja
;
He, Daifeng
- In:
Health economics
26
(
2017
)
11
,
pp. 1447-1458
Persistent link: https://www.econbiz.de/10011817473
Saved in:
9
How excluding some benefits from value assessment of new drugs impacts innovation
Cook, Joseph P.
;
Golec, Joseph
- In:
Health economics
26
(
2017
)
12
,
pp. 1813-1825
Persistent link: https://www.econbiz.de/10011817950
Saved in:
10
Effects of physician-directed pharmaceutical promotion on prescription behaviors : longitudinal evidence
Datta, Anusua
;
Dave, Dhaval
- In:
Health economics
26
(
2017
)
4
,
pp. 450-468
Persistent link: https://www.econbiz.de/10011815606
Saved in:
11
Inducing optimal substitution between antibiotics under open access to the resource of antibiotic susceptibility
Herrmann, Markus
;
Nkuiya, Bruno
- In:
Health economics
26
(
2017
)
6
,
pp. 703-723
Persistent link: https://www.econbiz.de/10011815734
Saved in:
12
Adverse and advantageous selection in the medicare supplemental market : a bayesian analysis of prescription drug expenditure
Li, Qian
;
Trivedi, Pravin K.
- In:
Health economics
25
(
2016
)
2
,
pp. 192-211
Persistent link: https://www.econbiz.de/10011541381
Saved in:
13
Free medicines thanks to retirement : impact of coinsurance exemption on pharmaceutical expenditures and hospitalization offsets in a national health service
Puig-Junoy, Jaume
;
García Gómez, Pilar
;
Casado Marin, …
- In:
Health economics
25
(
2016
)
6
,
pp. 750-767
Persistent link: https://www.econbiz.de/10011542205
Saved in:
14
Valuing trial designs from a pharmaceutical perspective using value-based pricing
Breeze, Penny
;
Brennan, Alan
- In:
Health economics
24
(
2015
)
11
,
pp. 1468-1482
Persistent link: https://www.econbiz.de/10011433995
Saved in:
15
Reconciling estimates of the value to firms of reduced regulatory delay in the marketing of their new drugs
Wilmoth, Daniel R.
- In:
Health economics
24
(
2015
)
12
,
pp. 1651-1656
Persistent link: https://www.econbiz.de/10011486883
Saved in:
16
Payments, promotion, and the purple pill
Ridley, David B.
- In:
Health economics
24
(
2015
)
1
,
pp. 86-103
Persistent link: https://www.econbiz.de/10011316672
Saved in:
17
Value-based differential pricing : efficient prices for drugs in a global context
Danzon, Patricia Munch
;
Towse, Adrian
;
Mestre …
- In:
Health economics
24
(
2015
)
3
,
pp. 294-301
Persistent link: https://www.econbiz.de/10011317796
Saved in:
18
Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement
Danzon, Patricia Munch
;
Mulcahy, Andrew W.
;
Towse, Adrian K.
- In:
Health economics
24
(
2015
)
2
,
pp. 238-252
Persistent link: https://www.econbiz.de/10011317852
Saved in:
19
Are physicians' prescribing decisions sensitive to drug prices? : evidence from a free-antibiotics program?
Li, Shanjun
;
Laxminarayan, Ramanan
- In:
Health economics
24
(
2015
)
2
,
pp. 158-174
Persistent link: https://www.econbiz.de/10011317888
Saved in:
20
Price-cap regulation, uncertainty and the price evolution of new pharmaceuticals
Shajarizadeh, Ali
;
Hollis, Aidan
- In:
Health economics
24
(
2015
)
8
,
pp. 966-977
Persistent link: https://www.econbiz.de/10011318463
Saved in:
21
Impact of FDA actions, DTCA, and public information on the market for pain medication
Bradford, David W.
;
Kleit, Andrew N.
- In:
Health economics
24
(
2015
)
7
,
pp. 859-875
Persistent link: https://www.econbiz.de/10011318473
Saved in:
22
Therapeutic substitution post-patent expiry : the cases of ACE inhibitors and proton pump inhibitors
Vandoros, Sotris
- In:
Health economics
23
(
2014
)
5
,
pp. 621-630
Persistent link: https://www.econbiz.de/10011305497
Saved in:
23
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron
;
Zhang, Yuting
- In:
Health economics
23
(
2014
)
11
,
pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Saved in:
24
Cost-offsets of prescription drug expenditures : data analysis via a copula-based bivariate dynamic hurdle model
Deb, Partha
;
Trivedi, Pravin K.
;
Zimmer, David M.
- In:
Health economics
23
(
2014
)
10
,
pp. 1242-1259
Persistent link: https://www.econbiz.de/10011308206
Saved in:
25
The determinants of pricing in pharmaceuticals : are US prices really so high?
Cabrales, Antonio
;
Jiménez-Martín, Sergi
- In:
Health economics
22
(
2013
)
11
,
pp. 1377-1397
Persistent link: https://www.econbiz.de/10010242974
Saved in:
26
Parallel imports and innovation in an emerging economy : the case of Indian pharmaceuticals
Mantovani, Andrea
;
Naghavi, Alireza
- In:
Health economics
21
(
2012
)
11
,
pp. 1286-1299
Persistent link: https://www.econbiz.de/10009670282
Saved in:
27
External referencing and pharmaceutical price negotiation
García-Mariñoso, Begoña
;
Jelovac, Izabela
;
Olivella, Pau
- In:
Health economics
20
(
2011
)
6
,
pp. 737-756
Persistent link: https://www.econbiz.de/10009129628
Saved in:
28
Investment in antiviral drugs : a real options approach
Attema, Arthur Ewoud
;
Lugnér, Anna K.
;
Feenstra, …
- In:
Health economics
19
(
2010
)
10
,
pp. 1240-1254
Persistent link: https://www.econbiz.de/10008758926
Saved in:
29
Spending on new drug development
Adams, Christopher P.
;
Brantner, Van Vu
- In:
Health economics
19
(
2010
)
2
,
pp. 130-141
Persistent link: https://www.econbiz.de/10008650591
Saved in:
30
Effects of the German reference drug program on ex-factory prices of prescription drugs : a panel data approach
Augurzky, Boris
;
Göhlmann, Silja
;
Greß, Stefan
; …
- In:
Health economics
18
(
2009
)
4
,
pp. 421-436
Persistent link: https://www.econbiz.de/10003844289
Saved in:
31
Competition between brand-name and generics-analysis on pricing of brand-name pharmaceutical
Kong, Ying
- In:
Health economics
18
(
2009
)
5
,
pp. 591-606
Persistent link: https://www.econbiz.de/10003845402
Saved in:
32
Optimal drug pricing, limited use conditions and stratified net benefits for Markov models of disease progression
Zaric, Gregory S.
- In:
Health economics
17
(
2008
)
11
,
pp. 1277-1294
Persistent link: https://www.econbiz.de/10003785601
Saved in:
33
Pharmaceutical promotion and GP prescription behaviour
Windmeijer, Frank
;
Laat, Eric A. A. de
;
Douven, Rudy
; …
- In:
Health economics
15
(
2006
)
1
,
pp. 5-18
Persistent link: https://www.econbiz.de/10003274073
Saved in:
34
Examining the link between price regulation and pharmaceutical R&D investment
Vernon, John A.
- In:
Health economics
14
(
2005
)
1
,
pp. 1-16
Persistent link: https://www.econbiz.de/10002550327
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->